Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity

Doxorubicin (DOX) is a well-known chemotherapeutic agent extensively applied in the field of cancer therapy. However, similar to other chemotherapeutic agents such as cisplatin, paclitaxel, docetaxel, etoposide and oxaliplatin, cancer cells are able to obtain chemoresistance that limits DOX efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashrafizadeh, Milad, Zarrabi, Ali, Hashemi, Farid, Zabolian, Amirhossein, Saleki, Hossein, Bagherian, Morteza, Azami, Negar, Bejandi, Atefe Kazemzade, Hushmandi, Kiavash, Ang, Hui Li, Makvandi, Pooyan, Khan, Haroon, Kumar, Alan Prem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697177/
https://www.ncbi.nlm.nih.gov/pubmed/33187385
http://dx.doi.org/10.3390/pharmaceutics12111084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697177/
https://www.ncbi.nlm.nih.gov/pubmed/33187385
http://dx.doi.org/10.3390/pharmaceutics12111084

Ejemplares similares